🔍

Abate As Industries Ltd (531658)

📊 BSE: 531658 🏢 Hospital 📢 Latest filing: 14 Oct 2026 📝 Analysis written: 13 Nov 2025

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Abate As' revenue was ₹22.8 Cr (-44.4% year on year, -32.8% on the previous quarter), and net profit ₹2.2 Cr (-0.3% year on year); the operating margin was 14.6%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹22.8	-44.4%	-32.8%
Operating profit	₹3.3	+33.5%	+7.7%
Net profit	₹2.2	-0.3%	-23.4%
EPS (₹)	0.08	—	-57.9%
Operating margin	14.6%	—	—

No EPS growth against Q1 FY26: 1:1 bonus in Jul 2025.

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Abate As Signs Rs 30 Lakh Franchise Deal with Franchise India for Nationwide Eye Hospital Expansion

🟡 NEUTRAL ⭐ 5/10

EXPANSION 📅 14 Oct 2026, 05:11 PM

Abate As Industries Ltd has entered into a service agreement with Franchise India Brands Limited effective October 14, 2026. The contract focuses on franchise development, documentation, lead generation, and partner recruitment to expand the 'ABATE EYE HOSPITAL' brand across India. The agreement size is Rs 30,00,000 (Rs 0.30 crore), which represents roughly 0.21% of TTM revenue of Rs 142 crore. The tenure of the agreement is 24 months, with payment structured around fixed consultancy and success-linked acquisition fees.

Agreement size fixed at INR 30,00,000/- (Rs 30 Lakhs)
Contract tenure established for 24 months effective from October 14, 2026
Commercial terms include fixed consultancy fees plus success-based fees per franchise partner recruited
Aimed at nationwide expansion of the 'ABATE EYE HOSPITAL' network via a franchise model

💡 Track subsequent quarterly updates to observe the pace of franchise sign-ups and any incremental revenue contribution from franchise fees.

Abate AS Industries Convenes 35th AGM on Sept 16, 2026; Sets Sept 9 Cut-Off Date

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 22 Aug 2026, 01:36 PM

Abate AS Industries Limited has issued the notice for its 35th Annual General Meeting (AGM) scheduled for September 16, 2026, via Video Conferencing. The cut-off date to determine shareholder voting eligibility is September 9, 2026. Remote e-voting will run from September 13 to September 15, 2026, alongside a book closure window from September 10 to September 16, 2026. The meeting will address routine annual business and director appointments, including a 5-year term for Independent Director Aboobaker Vattamkandathil.

35th AGM scheduled for September 16, 2026, at 03:00 PM IST via VC/OAVM
Cut-off date for remote e-voting eligibility set for September 09, 2026
Book closure period scheduled from September 10, 2026, to September 16, 2026
Remote e-voting window open from September 13, 2026 (09:00 AM) to September 15, 2026 (05:00 PM)

💡 Shareholders holding shares as of the September 9, 2026 cut-off date can cast their votes via CDSL remote e-voting platform prior to the AGM on September 16, 2026.

Abate AS Industries Issues 35th AGM Notice & FY26 Annual Report Link; AGM on Sept 16, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 22 Aug 2026, 01:35 PM

Abate AS Industries Limited has dispatched letters with the web-link for its FY 2025-26 Annual Report and 35th AGM Notice to shareholders without registered email addresses, in compliance with SEBI Regulation 36(1)(b). The 35th Annual General Meeting is scheduled for September 16, 2026, at 03:00 PM IST via Video Conferencing. The communication was sent based on beneficiary positions (Benpos) as of August 14, 2026. The filing also serves as a reminder for physical share owners to update their KYC details and dematerialize holdings.

35th AGM scheduled for September 16, 2026, at 03:00 PM IST via VC/OAVM
Intimation sent to unregistered email holders based on Benpos date of August 14, 2026
Annual Report for FY 2025–26 hosted and accessible via the company website
Mandatory KYC update reminder issued pursuant to SEBI circular dated May 07, 2024

💡 Shareholders can access the FY26 Annual Report online and note the AGM date of September 16, 2026, while ensuring KYC details are updated with the RTA.

Abate AS Industries Schedules 35th AGM for Sep 16, 2026; Sets Cut-Off Date as Sep 9

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 22 Aug 2026, 01:31 PM

Abate AS Industries Limited has announced its 35th Annual General Meeting (AGM) to be held on Wednesday, September 16, 2026, at 03:00 PM IST via Video Conferencing/OAVM. The company has fixed Wednesday, September 9, 2026, as the cut-off date to determine shareholder voting eligibility. Share transfer books and the Register of Members will remain closed from September 10 to September 16, 2026. Remote e-voting opens on September 13 at 09:00 AM IST and closes on September 15, 2026, at 05:00 PM IST.

35th AGM scheduled for September 16, 2026, at 03:00 PM IST via VC/OAVM
Cut-off date for e-voting eligibility set as Wednesday, September 9, 2026
Book closure period runs from September 10, 2026, to September 16, 2026 (both days inclusive)
Remote e-voting window active from September 13, 2026 (09:00 AM) to September 15, 2026 (05:00 PM)

💡 Shareholders looking to vote on AGM resolutions should hold shares as of the September 9, 2026 cut-off date and monitor the AGM proceedings and voting outcomes.

Abate As Industries Submits FY26 Annual Report; 35th AGM Scheduled on 16 Sep 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 22 Aug 2026, 01:29 PM

Abate AS Industries Limited has submitted its 35th Annual Report along with the AGM notice for FY 2025-26. The 35th Annual General Meeting will be conducted via Video Conferencing on Wednesday, September 16, 2026, at 3:00 PM IST. The cut-off date for determining voting rights is September 9, 2026, with remote e-voting running from September 13 to September 15, 2026. Statutory auditors noted in the internal controls report that the design of internal financial controls needs strengthening to be fully commensurate with the group's scale.

35th AGM to be held on September 16, 2026 at 3:00 PM IST via VC/OAVM.
Shareholder voting cut-off date fixed for September 9, 2026.
Remote e-voting scheduled from September 13, 2026 (9:00 AM) to September 15, 2026 (5:00 PM).
Book closure period defined from September 10, 2026 to September 16, 2026.
Statutory auditor observed that the design of internal financial controls needs enhancement.

💡 Eligible shareholders holding shares on the cut-off date (September 9, 2026) can participate in e-voting and review resolutions proposed at the AGM.

Abate As Industries Reports Rs 22.82 Cr Q1 Revenue, Proposes Major Healthcare Expansion

🟢 POSITIVE ⭐ 7/10

BOARD_MEETING 📅 13 Aug 2026, 05:51 PM

Abate As Industries reported Q1 FY27 revenue of Rs 22.82 Cr and a net profit of Rs 2.24 Cr. The board has proposed a significant expansion of its Memorandum of Association (MoA) to include super-specialty hospitals, diagnostic centers, and digital healthcare platforms. Key leadership moves include the re-appointment of Executive Director Dr. Muhammed Swadique for a 5-year term and the appointment of a new Independent Director with 20+ years of international experience. Notably, promoter holding has recently increased from 27.57% to 32.42%, signaling internal confidence.

Reported Q1 FY27 revenue of Rs 22.82 Cr and net profit of Rs 2.24 Cr.
Proposed amendment to MoA to allow entry into super-specialty hospitals, medical education, and digital health.
Re-appointed Dr. Muhammed Swadique as Executive Director for a 5-year term ending August 2031.
Appointed Mr. Aboobaker Vattamkandathil as Independent Director, bringing 20 years of finance and reinsurance experience.
Promoter holding increased by 4.85% to reach 32.42% as of the latest filing.

💡 Monitor the 35th Annual General Meeting on September 16, 2026, for shareholder approval of the business object expansion and any subsequent announcements regarding new hospital projects.

Abate As Industries: Rs 23.09 Cr Subsidiary Revenue in Q1; Re-appoints Directors for 5 Years

🟡 NEUTRAL ⭐ 6/10

BOARD_MEETING 📅 13 Aug 2026, 05:08 PM

Abate As Industries approved its Q1 FY27 results and a series of key leadership re-appointments for five-year terms. The company reported that its three subsidiaries contributed Rs 23.09 cr in revenue and Rs 2.08 cr in PAT for the quarter. Significantly, the board proposed an alteration to the Main Object clause of the Memorandum of Association, suggesting a potential shift or expansion in business focus. The 35th Annual General Meeting is scheduled for September 16, 2026, to formalize these changes.

Re-appointment of Dr. Muhammed Swadique as Executive Director for a 5-year term until August 13, 2031.
Three subsidiaries reported combined revenue of Rs 23.09 cr and PAT of Rs 2.08 cr for the quarter ended June 30, 2026.
Total assets of subsidiaries reached Rs 93.64 cr, representing approximately 56.7% of the company's Rs 165 cr net worth.
Proposed alteration of the Main Object clause (Clause III(A)(1)) of the Memorandum of Association.
35th Annual General Meeting (AGM) scheduled for September 16, 2026, via video conferencing.

💡 Investors should review the upcoming AGM notice to understand the specific details of the proposed change to the 'Main Object' clause, as this indicates the company's future strategic direction.

Abate As Industries Reports Q1 Cons. Revenue of ₹23.08 Cr; Appoints New Independent Director

🟡 NEUTRAL ⭐ 6/10

BOARD_MEETING 📅 13 Aug 2026, 04:55 PM

Abate As Industries approved its Q1 FY27 results, reporting a consolidated revenue of ₹23.08 crore and a net profit of ₹2.08 crore. The board appointed Mr. Aboobaker Vattamkandathil, a reinsurance professional with over 20 years of experience, as an Additional Independent Director for a 5-year term. Crucially, the company proposed an alteration to its Memorandum of Association (MoA) Main Object clause, suggesting a potential strategic shift. The 35th Annual General Meeting (AGM) is scheduled for September 16, 2026, to seek shareholder approval for these changes and director re-appointments.

Consolidated revenue for the quarter ended June 30, 2026, reached ₹23.08 crore.
Consolidated net profit after tax for the quarter stood at ₹2.08 crore.
Total assets of the three subsidiaries included in consolidation were reported at ₹93.64 crore.
Mr. Aboobaker Vattamkandathil appointed as Independent Director for a 5-year term starting August 13, 2026.
Proposed alteration of the Main Object clause in the Memorandum of Association to be voted on at the AGM.

💡 Investors should review the upcoming AGM notice to understand the specific details of the proposed 'Main Object' clause alteration, as this indicates the company's future business direction.

Abate As Industries Proposes Major MoA Expansion into Multi-Specialty Healthcare

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 13 Aug 2026, 04:41 PM

Abate As Industries has proposed a comprehensive alteration to its Memorandum of Association (MoA) to pivot towards a broader healthcare model, including super-specialty hospitals, diagnostic centers, and medical device manufacturing. The board has also approved the Q1 FY27 results and scheduled the 35th Annual General Meeting (AGM) for September 16, 2026. Management stability is reinforced with the re-appointment of Executive Director Dr. Muhammed Swadique for a five-year term. This strategic shift aims to align the company with high-growth healthcare verticals.

Proposed alteration of MoA to include establishing super-specialty hospitals, pathology labs, and medical device trading
Re-appointment of Dr. Muhammed Swadique as Executive Director for a 5-year term ending August 13, 2031
35th Annual General Meeting (AGM) scheduled for September 16, 2026, at 03:00 PM
Appointment of Mr. Aboobaker Vattamkandathil, a finance professional with 20+ years of experience, as Independent Director
Promoter holding recently increased from 27.57% to 32.42% as of March 2026

💡 Monitor the shareholder vote on the MoA alteration at the upcoming AGM and look for subsequent announcements regarding specific capital expenditure or project timelines for new hospital facilities.

Abate As Industries Proposes Expansion of Healthcare Objects and Re-appoints Key Directors

🟡 NEUTRAL ⭐ 5/10

BOARD_MEETING 📅 13 Aug 2026, 04:29 PM

Abate As Industries approved its Q1 FY27 financial results and scheduled its 35th Annual General Meeting (AGM) for September 16, 2026. A significant proposal was made to alter the Memorandum of Association (MoA) to broaden the company's scope into multi-speciality hospitals, diagnostic centers, and medical device manufacturing. The board also re-appointed Dr. Muhammed Swadique as Executive Director and appointed a new Independent Director with 20+ years of insurance experience. Despite a healthy net worth of ₹165 Cr and low debt of ₹2 Cr, the company faces a low ROCE of 0.9%.

Proposed expansion of MoA to include super-speciality hospitals, diagnostic centers, and medical device manufacturing
35th Annual General Meeting scheduled for September 16, 2026, via video conferencing
Re-appointment of Dr. Muhammed Swadique as Executive Director for a 5-year term until August 13, 2031
Appointment of Mr. Aboobaker Vattamkandathil as Independent Director for a 5-year term
Company maintains a low Debt-to-Equity ratio of 0.01 based on ₹2 Cr debt and ₹165 Cr net worth

💡 Investors should monitor the upcoming AGM for specific details on the execution timeline and capital allocation for the proposed healthcare expansion, given the current low ROCE of 0.9%.

Aug 13 Board Meeting: Abate As Industries to approve Q1 results and appoint Independent Director

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 10 Aug 2026, 04:20 PM

Abate As Industries Ltd has scheduled a board meeting for August 13, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. The board will also finalize the schedule and notice for the FY2025-26 Annual General Meeting (AGM) and appoint Mr. Aboobaker Vattamkandathil as an Additional Independent Director. This meeting is critical as the company currently reports zero operational revenue (TTM) despite a market capitalization of ₹144 Cr. Investors should monitor if the upcoming results show any shift toward active operations in the hospital sector.

Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results.
Appointment of Mr. Aboobaker Vattamkandathil (DIN: 10059868) as Additional Independent Director.
Finalization of AGM details including book closure and e-voting dates for FY2025-26.
Trading window for insiders closed from August 10, 2026, until 48 hours after the results declaration.
Company reported ₹0 Cr revenue for the last four consecutive quarters.

💡 Watch for the Q1 results on August 13 to see if the company has commenced any revenue-generating operations, given the current TTM revenue of ₹0 Cr.

View All 531658 Announcements on Live Market Tracking →